Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis

• Main Authors: Caterina De Sarro (Author), Francesca Bosco (Author), Agnese Gagliardi (Author), Lorenza Guarnieri (Author), Stefano Ruga (Author), Antonio Fabiano (Author), Laura Costantino (Author), Antonio Leo (Author), Caterina Palleria (Author), Chiara Verduci (Author), Vincenzo Rania (Author), Michael Ashour (Author), Luca Gallelli (Author), Rita Citraro (Author), Giovambattista De Sarro (Author)
• Format: Book
• Published: MDPI AG, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The treatment of psoriasis has made considerable progress with biologicals, including tumor necrosis factor inhibitors, and recently, monoclonal antibodies inhibiting directly interleukin (IL) 17, IL-23, or both IL-12/23. Newer biologicals are directed to the interleukin pathway and appe...